Phase I clinical trial of autologous NK cell therapy using novel expansion method in patients with advanced digestive cancer

Table 4 Tumor response

No. of patients	Response				Response rate (%) (95 % CI)	Disease control rate (%) (95 % CI)
No. of patients	CR	PR	SD	PD	Response rate (%) (95 % CI)	Disease control rate (%) (95 % CI)
ITT population n = 12	0	0	5	7	0 (0)	41.7 (15.17–72.33)
PP population n = 10	0	0	5	5	0 (0)	50.0 (18.71–81.29)

ITT intention -to-treat, PP per protocol, CR complete response, PR Partial response, SD stable disease, PD progressive disease, 95 %CI 95 % confidence interval

ISSN: 1479-5876